Lifecome Biochemistry Co Ltd (002868) — Capital Reinvestment Ratio
Lifecome Biochemistry Co Ltd (002868) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥13.24 Million) in capital expenditures (CN¥3.02 Million). Check 002868 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lifecome Biochemistry Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Lifecome Biochemistry Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Lifecome Biochemistry Co Ltd.
Annual Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd from 2012 to 2024. See free cash flow generation of Lifecome Biochemistry Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | CN¥141.41 Million | CN¥125.06 Million | ▼ -91.3% |
| 2021 | 10.16x | CN¥35.17 Million | CN¥357.17 Million | ▲ +263.0% |
| 2020 | 2.80x | CN¥90.72 Million | CN¥253.79 Million | ▲ +65.0% |
| 2019 | 1.70x | CN¥74.09 Million | CN¥125.60 Million | ▲ +190.0% |
| 2018 | 0.58x | CN¥83.70 Million | CN¥48.93 Million | ▲ +202.7% |
| 2017 | 0.19x | CN¥96.11 Million | CN¥18.56 Million | ▲ +76.5% |
| 2016 | 0.11x | CN¥135.41 Million | CN¥14.82 Million | ▼ -64.9% |
| 2015 | 0.31x | CN¥127.11 Million | CN¥39.65 Million | ▼ -20.6% |
| 2014 | 0.39x | CN¥62.76 Million | CN¥24.66 Million | ▼ -46.4% |
| 2013 | 0.73x | CN¥77.68 Million | CN¥57.00 Million | ▼ -9.2% |
| 2012 | 0.81x | CN¥60.92 Million | CN¥49.25 Million | — |